| 000 | 01799 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515014359.0 | ||
| 264 | 0 | _c20061214 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2005.042630 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPham, T | |
| 245 | 0 | 0 |
_aAn international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cDec 2006 |
||
| 300 |
_a1620-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aProfessional Practice _xstatistics & numerical data |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aLandewé, R | |
| 700 | 1 | _avan der Linden, S | |
| 700 | 1 | _aDougados, M | |
| 700 | 1 | _aSieper, J | |
| 700 | 1 | _aBraun, J | |
| 700 | 1 | _aDavis, J | |
| 700 | 1 | _aRudwaleit, M | |
| 700 | 1 | _aCollantes, E | |
| 700 | 1 | _aBurgos-Vargas, R | |
| 700 | 1 | _aEdmonds, J | |
| 700 | 1 | _aOlivieri, I | |
| 700 | 1 | _avan der Horst-Bruinsma, I | |
| 700 | 1 | _aMielants, H | |
| 700 | 1 | _aStone, M | |
| 700 | 1 | _aEmery, P | |
| 700 | 1 | _avan der Heijde, D | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 65 _gno. 12 _gp. 1620-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2005.042630 _zAvailable from publisher's website |
| 999 |
_c16077868 _d16077868 |
||